Travere Therapeutics Cash from Financing (TTM) Insights

Travere Therapeutics Inc (TVTX)

6.81 +0.05 (+0.74%) USD | NASDAQ | May 08, 16:00

6.81 0.00 (0.00%) After-Hours: 19:21

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
March 31, 2024	1.231M
December 31, 2023	218.75M
September 30, 2023	219.18M
June 30, 2023	222.09M
March 31, 2023	220.66M
December 31, 2022	117.57M
September 30, 2022	150.24M
June 30, 2022	150.37M
March 31, 2022	149.84M
December 31, 2021	231.68M
September 30, 2021	223.51M
June 30, 2021	220.75M
March 31, 2021	329.24M
December 31, 2020	127.71M
September 30, 2020	102.77M
June 30, 2020	102.38M
March 31, 2020	-6.74M
December 31, 2019	-2.077M
September 30, 2019	-1.647M
June 30, 2019	230.05M
March 31, 2019	233.46M

Date	Value
December 31, 2018	231.86M
September 30, 2018	232.70M
June 30, 2018	7.579M
March 31, 2018	2.597M
December 31, 2017	5.445M
September 30, 2017	-0.96M
June 30, 2017	-2.757M
March 31, 2017	-2.777M
December 31, 2016	-3.849M
September 30, 2016	2.427M
June 30, 2016	-41.72M
March 31, 2016	-38.70M
December 31, 2015	101.60M
September 30, 2015	99.84M
June 30, 2015	143.49M
March 31, 2015	196.08M
December 31, 2014	95.32M
September 30, 2014	95.32M
June 30, 2014	112.91M
March 31, 2014	59.22M
December 31, 2013	28.98M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-6.74M

Minimum

Mar 2020

329.24M

Maximum

Mar 2021

150.38M

Average

150.30M

Median

Cash from Financing (TTM) Benchmarks